Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Laboratory Mouse Cancer Free

<< Previous

Bullboard Posts

Next >>

Comment by plantraderon Jun 19, 2024 8:19am

145 Views

Post# 36095572

RE:Laboratory Mouse Cancer Free

How is the tumor "treated" or inoculated? Is it an IV, and then X-ray activation? Or is the tumor treated in more of a local manner? What I'm getting at is, how pervasive is the existence of Rutherrin in case there are metastases? Or would big problem be that it has to be a directly accessible tumor? Thanks in advance, I might have missed that info.

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles